January 17, 2024
The Biden administration and advocacy groups agreed to end a government appeal of a D.C. federal judge's decision to vacate a 2021 rule that allowed insurers to not count coupons or discounts provided by pharmaceutical companies to patients toward patients' deductibles and out-of-pocket maximums.
November 29, 2023
The Biden administration says it is appealing a D.C. federal judge's decision to nix a 2021 rule that allowed insurers to exclude prescription manufacturer coupons from counting toward patients' deductibles and out-of-pocket maximums.
October 04, 2023
The D.C. federal court has sided with patient advocacy groups and vacated a 2021 rule that allowed insurers to exclude prescription manufacturer coupons from annual cost-sharing caps.